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Background: There are no randomised controlled trials to demonstrate whether lifestyle modifications can improve
pregnancy outcomes of gestational diabetes mellitus (GDM) diagnosed by the International Association of Diabetes
and Pregnancy Study Group’s (IADPSG) criteria. We tested the effectiveness of lifestyle modifications implemented
in a 3-tier’s shared care (SC) on pregnancy outcomes of GDM.
Methods: Between December 2010 and October 2012, we randomly assigned 700 women with IADPSG-defined
GDM but without diabetes at 26.3 (interquartile range: 25.4-27.3) gestational weeks in Tianjin, China, to receive
SC or usual care (UC). The SC group received individual consultations and group sessions and performed regular
self-monitoring of blood glucose compared to one hospital-based education session in the UC group. The outcomes
were macrosomia defined as birth weight≥ 4.0 kg and the pregnancy-induced hypertension (PIH).
Results: Women in the SC (n = 339) and UC (n = 361) groups delivered their infants at similar gestational weeks.
Birth weight of infants in the SC group was lower than that in the UC group (3469 vs. 3371 grams, P = 0.021). The
rate of macrosomia was 11.2% (38/339) in the SC group compared to 17.5% (63/361) in the UC group with relative
risk (RR) of 0.64 (95% CI: 0.44-0.93). The rate of PIH was 8.0% (27/339) in the SC compared to 4.4% (16/361) in the UC
with RR of 1.80 (0.99-3.28). Apgar score at 1 min < 7 was lower but preeclampsia was higher in the SC than in the UC.
Conclusions: Lifestyle modifications using a SC system improved pregnancy outcomes in Chinese women with GDM.
Trial registration: Clinicaltrials.gov; NCT01565564.
Keywords: Randomised controlled trial, Gestational diabetes mellitus, Shared care, Self-monitoring of blood glucose,
Lifestyle intervention, Macrosomia, Large for gestational ageBackground
Gestational diabetes mellitus (GDM) increases the risk
of adverse pregnancy outcomes including macrosomia
[1], preterm birth [1,2], shoulder dystocia, birth trauma
and neonatal morbidities [3-5]. GDM also predisposes* Correspondence: yxl@hotmail.com
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unless otherwise stated.the offspring to high risk of childhood obesity [6], and
the mothers to high risk of diabetes in the long run [7].
In the Hyperglycaemia and Adverse Pregnancy Outcomes
(HAPO) Survey [8], there were strong and continuous
associations of maternal plasma glucose levels with in-
creased birth weight and C-peptide levels in cord-blood
with no apparent thresholds. Two randomised controlled
clinical trials evaluated the efficacy of treatment of mild
GDM on pregnancy outcomes [9,10]. The Australian
Carbohydrate Intolerance Study in Pregnant Women
(ACHOIS) [10] reported that intensive intervention in
women with GDM defined by a 75-gram 2-hour orald. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Organization’s criteria [11] reduced the rate of serious
perinatal complications (defined as death, shoulder dys-
tocia, bone fracture, and nerve palsy). Among individual
pregnancy outcomes, the rates of macrosomia and pre-
eclampsia were significantly reduced [10]. Another multi-
center randomised trial from the US [9] reported that
intensive intervention in women with GDM defined by a
100-gram 3-hour (OGTT) and the Fourth International
Workshop-Conference on GDM’s criteria [12] did not re-
duce the predefined composite endpoint of neonatal mor-
bidity and its components (stillbirth or neonatal death,
hypoglycemia, etc.) but significantly reduced the rates of
macrosomia, shoulder dystocia and pregnancy-induced
hypertension (PIH) [9]. In 2010, the International Associ-
ation of Diabetes and Pregnancy Study Groups (IADPSG)
recommended new criteria to define GDM with a much
lower cutoff point for the fasting glucose than previous
criteria for diagnosis of GDM [13], which diagnosed more
cases in Asian and European pregnant women [14,15].
However, there is no randomised trials to demonstrate
that intensive intervention is able to achieve similar effects
on pregnancy outcomes as among GDM diagnosed by
either the WHO’s criteria [11] or the Fourth International
Workshop-Conference on GDM’s criteria [12].
In 1998, Tianjin implemented a universal screening for
GDM [16]. Between 1999 and 2008, the prevalence of
GDM in Tianjin had increased from 2.4% to 6.8% [17].
Although diabetes education has been shown to be effect-
ive in improving glycaemic control [18], the challenge lies
in care organization to maximise the synergism between
primary, secondary and tertiary care [19]. This study
tested that lifestyle modification implemented in a shared
care (SC) system among care providers was able to re-
duce adverse pregnancy outcomes as compared to
usual care among women with GDM diagnosed by the
IADPSG’s criteria [13]; and evaluated the feasibility of
utilizing the 3-tier care delivery to provide a pragmatic




Tianjin is a metropolitan city in Northern China, ranking
fourth in population size (12.8 millions) among Chinese
cities. In urban Tianjin, antenatal care was shared by a
3-tier prenatal care system consisting of 1). 65 primary
hospitals; 2). 6 district-level Women and Children’s
Health Centres (WCHC) and other secondary obstetric
hospitals; and 3). A city-level Tianjin WCHC (TWCHC)
and other tertiary hospitals. Antenatal care was delivered
in a relatively structured manner [1,16]. All pregnant
women were registered at a primary hospital with regular
antenatal clinic visits until 32nd gestational week. Thenthey would be referred to one of the 25 secondary or
tertiary obstetric hospitals at their choice where they
would be managed till delivery. All pregnant women
were offered a non-fasting 50-gram 1-hour glucose chal-
lenge test (GCT) at primary hospitals between 24th and
28th weeks of gestation. Women with plasma glucose (PG)
at GCT ≥7.8 mmol/L were referred to TWCHC GDM
Clinic, where they underwent a standard 75-gram 2-hour
oral glucose tolerance test (OGTT). GDM was diagnosed
according to the IADPSG’s criteria, i.e., having met any
of the cutoff points: fasting PG ≥5.1 mmol/L, 1-hour
PG ≥10.0 mmol/L or 2-hour PG ≥8.5 mmol/L [13].
Study design
This was a randomised controlled effectiveness trial nested
in the 3-tier prenatal care system of Tianjin, China. All
women confirmed with GDM were invited to participate
in the trial unless they had one or more of the following
exclusion criteria: 1). The OGTT had met the diagnostic
criteria of diabetes, i.e., fasting PG ≥ 7.0 mmol/L, 2-hour
PG ≥ 11.1 mmol/L or HbA1c ≥ 6.5% (48 mmol/mol) [20];
2). Younger than 18 years of age; 3). Non-singleton preg-
nancy; 4). Maternal-foetal ABO blood type incom-
patibility; and 5). Maternal diseases such as chronic
hypertension, thyrotoxicosis, prepregnancy diabetes and
use of long-term medications that might affect glucose
metabolism. Between 13 December 2010 and 11 October
2012, 19847 pregnant women were screened at primary
hospitals and 2921 women were referred to TWCHC
who underwent the 75-gram OGTT. Of them,1440
women were diagnosed to have GDM and we assessed
1388 women with GDM for their eligibility for the study
(52 women with GDM diagnosed on Saturday were not
invited to participate in the late stage of the fieldwork
due to manpower limitations). Of them, 440 women with
GDM were excluded due to having met one or more of
exclusion criteria, refusal to participate, there being
error/s in randomisation on the day (Figure 1). A total of
948 women were randomly assigned to receive either
shared care (SC) or usual care (UC). However, during
Nov 2010 to July 2011, separate areas for intervention/
follow-up in the two groups were unavailable due to renova-
tion of the whole building of TWCHC and data collection
from the UC women was performed by the intervention
staff members, the 242 women entering the trial during this
period also received unintentional intervention. Therefore
these women were excluded from the analysis. Among the
706 women entering the trial not during that period, one
woman in the UC group and five women in the SC group
delivered their infant outside Tianjin, 700 women (SC =
339; UC = 361) were available in the analysis (Figure 1). A
simple randomization procedure without replacement
(i.e., by the time sequence of visits to the clinic and a list
of priori computer-generated random assignment status
Assessed for eligibility
from 13 Dec 2010 to 11 Oct 2012 (n=1388) 
(52 not assessed)
Exclusion of 440 women with GDM due to: 
Met exclusion criteria (n=174)
with DM (n=122)
-Younger than 18 years of age (n=0)
-Non-singleton pregnancy (n=20)
-ABO blood type incompatibility (n=1)
-Maternal diseases (n=31)
Refusal (n=222)
Error/s in randomisation on the day (n=44)
Analysed (n=361) 
Excluded from analysis
(n of lost to follow-up =1)
Lost to follow-up (due to delivery of the baby 
elsewhere) (n=1) 
Not attended the 34th gestational week’s follow-up 
(n=140)
Allocated to usual care (n= 362)
Received allocated usual care (n=362 )
Did not receive allocated usual care (n=0)
Lost to follow-up (due to delivery of the baby 
elsewhere) (n=5) 
Not attended the 34th gestational week’s follow-
up (n=81)
Allocated to shared care (n=344)
Received allocated shared care (n=344)
Did not receive allocated shared care (n=0)
Analysed (n=339) 
Excluded from analysis
(n of lost to follow-up =5)
Randomized (n=948)
Exclusion of 242 women with GDM 
diagnosed from 10 Nov 2011 to 31 Jul 2012
Diagnosed GDM from 13 Dec 2009 to 9 Nov 2011 or 
from 1 August 2012 to 11 Oct 2012 (n=706)
-Diagnosed 
Figure 1 Patient flow diagram.
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the intervention team members. The women with GDM
in the trial but not the research team members were
masked to the random assignment.
Usual care
As usual practice, all women with GDM were offered a
group education class lasting for 30–40 minutes at the
TWCHC GDM clinic delivered by a diabetes educator
who was not part of the SC team. During this session,
they received advice on diet and physical activity but
were not specifically taught to perform self monitoring of
blood glucose (SMBG). For the UC women, insulin treat-
ment was recommended if HbA1c ≥6.5% (48 mmol/mol)
during follow-up. However, use of insulin after being hos-
pitalised for delivery was not standardised. The UC and SC
care protocol is listed in Additional file 1.Shared care
We adapted the protocol of the intervention arm in the
ACHOIS trial [10] to suit the cultural needs in our study
for women assigned to the SC group. The additional
intervention of SC was delivered by an intervention
team from TWCHC, consisting of trained nurses and
doctors. All women in the SC group were offered an
individualised dietary advice and physical activity coun-
selling at entry to the trial. Different energy intakes were
recommended based on prepregnacy body mass index
(BMI) classification for Chinese adults [21] with obese/
overweight women being advised to have moderate re-
striction in total energy, i.e., 35 kcal/day/kg for one kilo-
gram body weight per day in pregnancy for women with
pre-pregnancy BMI at <18.5 kg/m2; 30–35 kcal/day for
one kilogram body weight in pregnancy for women with
pre-pregnancy BMI at 18.5-23.9 kg/m2; 25–30 kcal/day/kg
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25 kcal/day/kg for women with pre-pregnancy BMI at
28.0 kg/m2 and more. All women were asked to be
engaged in at least 30 minutes of light to moderate phys-
ical activity daily, i.e., walking. All women were offered a
free glucose meter with memory function and free test
strips. They were asked to perform SMBG, 4 times a day for
the initial two weeks and then daily at different time points
in rotation (pre-breakfast and 2 hours after three meals).
The target of glycaemic control was ≥3.5- ≤ 5.1 mmol/l for
fasting capillary blood glucose and ≤7.0 mmol/L for 2-hour
postprandial capillary blood glucose up to 36th gestational
week and ≤8.0 mmol/L from 36th week onwards. If blood
glucose values exceeded the target values two times or more
during a 2-week interval or the 2-hour postprandial capillary
blood glucose exceeded 9.0 mmol/L once during a 1-week
period, insulin therapy would be recommended by the
intervention team and started by a senior obstetrician. At
30th and 34th gestational weeks, women in the SC group
were offered two additional individualised sessions to
reinforce diet, physical activity and SMBG. In addition
to individualised counselling at TWCHC, women in the
SC group were offered group education sessions each
lasting for 2 hours at 27th, 29th and 33rd gestational
weeks at TWCHC or a place close to their neighbour-
hood contingent upon their gestational week at diagno-
sis of GDM. The obstetric care of the SC women was
the same as the UC women.
Primary and secondary clinical outcomes
The primary outcome was macrosomia defined as birth
weight ≥4000 grams. We also used large for gestational
age (LGA) as a clinical outcome defined using the
Tianjin local reference. Standard birth weights were
obtained from all hospital deliveries for calibration to
estimate LGA. The hospital discharge notes and the
electronic medical records were retrieved from the
Central Antenatal Care Database of Tianjin at the end
of the study. The secondary outcome was incident PIH.
The hospital discharge notes and the electronic medical
notes for the entire antenatal care process were re-
trieved from the Central Antenatal Care Database of
Tianjin at the end of the study. The case notes of PIH
diagnosis and episodes of high BP were reviewed by an
obstetrician (L.D.) who was not involved in the man-
agement of the women of GDM and masked to the as-
signment status. Incident PIH was diagnosed by first
presence of gestational hypertension or preeclampsia/
eclampsia after entering the trial. Gestational hyper-
tension was defined as systolic/diastolic blood pres-
sure (SBP/DBP) ≥ 140/90 mmHg; preeclampsia was
defined as SBP/DBP ≥ 140/90 mmHg with proteinuria
(+or more). Priori set powers were 85% to detect a
40% risk reduction for macrosomia and 80% to detecta 37% risk reduction for PIH at a 5% type I error if two-
sided likelihood ratio test was used, which seemed to be
achievable [9].Data collection
Before the fieldwork, fieldwork manuals were compiled
and all personnel involved in the trial received at least
1-day training on protocols, intervention, care pro-
cesses. The intervention team received at least 1-week
additional training on intervention techniques. A series
of pilot studies were conducted to confirm the feasibil-
ity in administering the questionnaires and streamline
data collection. Data were collected in a longitudinal
way starting from the first antenatal visit and screening
visit for GDM at primary hospitals, and visits at the
TWCHC GDM clinic and at postpartum. The patient
health questionnaire (PHQ)-9 was a validated tool to
detect depression in general and diabetic Chinese popu-
lations in Hong Kong [22-24] which was also adminis-
tered at 34th gestational week. Physical activity was
collected with a validated questionnaire in 2002 China
National Nutrition and Health Survey [25] at 34th ges-
tational week. A 24-hour food recall method was used
to estimate energy intake. Maternal body weight and
other maternal and neonatal outcome measures were
documented at routine antenatal visits and delivery.
Ethical approval was obtained from the Clinical Ethics
Committee of TWCHC and informed consent was ob-
tained from all participants.Statistical analysis
The Statistical Analysis System (Release 9.30; SAS Institute,
Cary, NC) was used to analyse the data. All data were
expressed as mean (standard deviation, SD) or median
(interquartile range, IQR) as appropriate. The intention-
to-treat principle was followed in the data analysis. Body
weight at the first antenatal care visit was treated as pre-
pregnancy body weight due to relatively stable maternal
weight in the first trimester of pregnancy [26]. Preterm
birth was defined as gestational age at term less than 37
weeks. We used Chi-squared test (or Fisher’s exact test
where appropriate) to compare categorical variables and
the Student’s t test for continuous variables. We used
Wilcoxon two-sample test if normal distribution was
rejected by checking the Q-Q plot. The effects of SC
compared to UC on predefined and post-hoc pregnancy
outcomes were expressed as relative risk (RR) and relative
risk reduction and their 95% confidence intervals (CI).
Relative risk was estimated by prevalence ratio [27].
Subgroup analysis was performed to examine the ef-
fect size of SC among women with GDM diagnosed by
the IADPSG’s criteria only (n = 227) and among those
women with GDM diagnosed by both the IADPSG’s
Table 1 Clinical and biochemical characteristics of pregnant










At the 1st antenatal care visit
Age, year 29.7(3.2) 29.9(3.5) 0.475
Ethnicity




Current smoker 3(0.8%) 4(1.2%)
Alcohol intake 0.507
Ex-occasional drinker 97(26.9%) 79(23.3%)
Current occasional drinker 14(3.9%) 16(4.7%)
Body height, cm 163(4.5) 162(5.1) 0.091
Prepregnancy BMI, kg/m2 23.4(3.9) 22.9(3.6) 0.111
BMI classification 0.365
Below 18.5 (underweight) 23(6.4%) 25(7.4%)
18.0-23.9 (normal weight) 202(56.0%) 206(60.8%)
24.0-27.9 (overweight) 91(25.2%) 77(22.7%)
28.0 and above (obesity) 45(12.5%) 31(9.1%)
Parity
0 342(95.0%) 323(95.3%) 0.870
1 and more 18(5.0%) 16(4.7%)
Systolic BP, mmHg 107(10.2) 108(10.9) 0.742
Diastolic BP, mmHg 69(7.5) 70(7.8) 0.339
Gestational age at the first visit,
weeks
10.8(2.3) 10.8(2.4) 0.593
At screening for and diagnosis
of GDM
GCT, mmol/L‡ 8.9(8.3-9.8) 9.0(8.4-9.8) 0.364
Systolic BP, mmHg 109(10.1) 109(10.7) 0.786
Diastolic BP, mmHg 69(7.6) 70(7.5) 0.554
HbA1c, % 5.0(0.5) 5.0(0.5) 0.771
OGTT
Fasting PG, mmol/L 5.0(0.5) 5.1(0.6) 0.084
1-h PG, mmol/L 10.0(1.3) 10.1(1.4) 0.366
2-PG, mmol/L 8.4(1.4) 8.4(1.2) 0.983
Fasting insulin, mIU/L‡ 8.7(5.7-12.8) 9.0(5.6-12.8) 0.867
2-h insulin, mIU/L‡ 86.1(51.1-128.8) 82.6(50.9-123.1) 0.703
Weight gain at OGTT, kg 9.7(4.4) 9.8(4.4) 0.774
Gestational age at OGTT, weeks‡ 26.3(25.4-27.1) 26.3(25.4-27.4) 0.410
Abbreviations: BMI body mass index, BP blood pressure, GDM gestational
diabetes mellitus, GCT glucose challenge test, HbA1c haemoglobin A1c,
OGTT oral glucose tolerance test, PG plasma glucose.
†P values were derived from Chi-square Test, Fisher’s Exact Test, or Student T
Test unless specified.
‡Data were reported as median (interquartile range) and P values were
derived from Wilcoxon Two-Sample Test.
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criteria (n = 473) [11].
Sensitivity analysis was performed with re-inclusion of
130 SC women (3 lost to follow-up) and 112 UC women
(3 lost to follow-up) entering the trial during Nov 2010 to
July 2011 and further adjustment for other covariables.
Results
Characteristics of the trial women
The mean age of the 700 subjects in the trial was 29.8
(SD: 3.3) years and 95.1% of them were nulliparous and
97.0% were of Han ethnicity. These women had their
first antenatal care visit at 10.6 (IQR: 9.3 to 12) gesta-
tional weeks and were enrolled into the trial at 26.3
(IQR: 25.4 to 27.3) gestational weeks. The 1-hour 50-gram
GCT and 2-hour 75-gram OGTT results were similar be-
tween the two groups. Both groups had similar BMI at
their first antenatal care visit and similar weight gain from
their first antenatal care visit to the date when OGTT was
performed. The women assigned to the SC group had a
marginally shorter body height and had a marginally higher
fasting PG at the OGTT than the UC group (Table 1).
Compliance of the SC women
The SC women had a moderate compliance to the inter-
vention protocol with 66.7% attending all three individua-
lised education sessions and 60.8% attending at least one
group education session. There was a higher frequency
reaching the physical activity target in the SC group than
in the UC group. However, energy intake and HbA1c were
similar in the two groups. As a result, among the SC
women who returned for 30th and 34th gestational week
follow-ups, 93.5% and 80.6% achieved the glycaemic con-
trol target (Table 2).
Pregnancy outcomes
The rate of macrosomia was 11.2% (38/339) in the SC group
compared to 17.5% (63/361) in the UC group with RR of
0.64 (95% CI 0.44-0.93) (Table 3). The rate of PIH was 8.0%
(27/339) in the SC group compared to 4.4% (16/361) in the
UC group with RR of 1.80 (0.99-3.28). After adjustment
for borderline significant variables, i.e., body height
and fasting PG at OGTT, the RRs of SC versus UC for
macrosomia and PIH remained the same (macroso-
mia:0.66, 95% CI: 0.45-0.95; PIH: 1.77, 95% CI: 0.98-3.21).
Infants born to the women in the SC group had a lower
birth weight by 98 grams (SC vs. UC: 3469 versus 3371
grams, P = 0.021). The rate of LGA was 13.0% (44/
339) in the SC group and 19.9% (72/361) in the UC
group with a RR of 0.65 (95% CI 0.46-0.92). After adjust-
ment for borderline significant variables, the RR of SC
versus UC for LGA was 0.66 (95% CI: 0.47-0.93). The
rate of preeclampsia was significantly higher in the SC
group than in the UC group (5.3% vs. 2.2%, P = 0.031)
Table 2 Clinical and biochemical characteristics of pregnant women after enrollment to before delivery by assignment
Usual Care (n = 361) Shared Care (n = 339)
Variables Mean (SD) or n(%) Mean (SD) or n(%) P Value†
Attended individual education sessions
One session - 66(19.5%)
Two sessions - 47(13.9%)
Three sessions - 226(66.7%)
Attended group education sessions
None - 133(39.2%)
One session only - 101(29.8%)
Two and more sessions - 105(31.0%)
At 30th gestational weeks
Attended the 30 gestational week follow-up - 247(72.9%)
Weight gain from entry to 30th gestational week, kg/weeka 0.1(0.5)
Number of self-monitoring of blood glucose - 52(22)
Glycaemic control target achieved - 231(93.5%)
Energy intake, Kcal/day - 1832(347)
At 34th gestational weeks
Attended the 34th gestational week follow-up 221(61.2%) 252(74.3%) <0.001
Weight gain from entry to 34th gestational week, kg/weeka 0.31(0.32) 0.23(0.35) 0.012
Total number of self-monitoring of blood glucose - 72(24)
Glycaemic control target achieved - 203(80.6%)
Energy intake, Kcal/dayaa 1899(352) 1886(344) 0.718
HbA1c, %ab 5.2(0.5) 5.2(0.5) 0.252
HbA1c, mmol/mol 33(3) 33(3) 0.252
Insulin use 1(0.3%) 4(1.2%) 0.156
Commuting in the past monthac 0.731
Stay at home 103(46.6%) 114(45.2%)
Public transportation 64(29.0%) 71(28.3%)
Driving 39(17.7%) 53(21.1%)
Walking/biking 15(6.8%) 13(5.2%)
Engaged in leisure time physical activity in the past month: yes vs. noac 172(77.8%) 212(84.5%) 0.065
Reaching physical activity target in the past month (30 min per time, ≥7 times per week)ac 57(25.8%) 86(34.3%) 0.045
Patient health questionnaire (PHQ-9) Score as a continuous variablea 5.1(2.3) 4.9(2.6) 0.389
Patient health questionnaire (PHQ-9) Score as a categorical variablea 0.548
≥15 (major depression) 1(0.5%) 2(0.8%)
10-14 (minor depression) 8(3.5%) 14(5.6%)
<10 211(95.9%) 236(93.7%)
At delivery
Weight gain during pregnancy, kgb 15.7(6.4) 15.5(6.5) 0.785
Weight gain from 34th gestational week to delivery, kg/weekc 0.62(0.54) 0.61(0.60) 0.896
Insulin use 18(5.0%) 25(7.4%) 0.188
The number of obstetric visits since 28th gestational weeksd 7.6(2.5) 7.8(3.0) 0.509
†P values were derived from Chi-square Test, Fisher’s Exact Test, or Student T Test unless specified.
Valid sample size of the usual care vs. the shared care: a220 vs. 252, aa136 vs. 252, ab220 vs. 250, ac221 vs. 251, b322 vs. 305; c203 vs. 231; d164 vs. 207.
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Table 3 Pregnancy outcomes of women with gestational diabetes mellitus by assignment
UC (n = 361) SC (n = 339) SC vs. UC SC vs. UC
Outcomes Mean (SD) or n(%) Mean (SD) or n(%) P value Unadjusted RR (95% CI) Adjusted RR† (95% CI)
Delivery at a tertiary hospital 237(65.7%) 237(69.9%) 0.228
Gestational weeks at delivery 39.2(2.1) 39.4(2.9) 0.243
Primary outcome
Birth weight ≥4.0 kg 63(17.5%) 38(11.2%) 0.019 0.64(0.44-0.93) 0.66(0.45-0.95)
Secondary outcome
Pregnancy-induced hypertension 16(4.4%) 27(8.0%) 0.052 1.80(0.99-3.28) 1.77(0.98-3.21)
Other infant outcomes
Birth weight, g 3469(574) 3371(530) 0.021
Body stature of neonates, cm 50.2(1.9) 50.1(1.8) 0.248
Infant male gender 190(52.9%) 204(60.4%) 0.048
Large for gestational age‡ 72(19.9%) 44(13.0%) 0.013 0.65(0.46-0.92) 0.66(0.47-0.93)
Birth weight ≥4.5 kg 10(2.8%) 7(2.1%) 0.541 0.75(0.29-1.94) 0.75(0.28-1.99)
Birth weight < 2.5 kg 14(3.9%) 14(4.1%) 0.865 1.06(0.52-2.20) 1.00(0.48-2.08)
Apgar score at 1 min <7 7(1.9%) 0(0%) 0.016
Neonatal hypoglycemia§ 4(1.1%) 2(0.6%) 0.457 0.53(0.10-2.89) 0.55(0.10-3.09)
Birth trauma or shoulder dystocia 0 0 - - -
Bone fracture 0 0 - - -
Stillbirth or neonatal death 4(1.1%) 4(1.2%) 0.929 1.06(0.27-4.22) 1.01(0.27-3.84)
Other maternal or delivery outcomes
Induced labor 1(0.3%) 0 -
Preterm birth 28(7.8%) 18(5.3%) 0.192 0.68(0.39-1.21) 0.64(0.36-1.14)
Premature rupture of membrane 69(19.1%) 49(14.5%) 0.100 0.76(0.54-1.06) 0.74(0.53-1.04)
Caesarean delivery 233(64.5%) 239(70.5%) 0.093 1.09(0.99-1.21) 1.09(0.98-1.21)
Preeclampsia 8(2.2%) 18(5.3%) 0.031 2.40(1.06-5.44) 2.35(1.05-5.26)
Gestational hypertension 8(2.2%) 9(2.7%) 0.706 1.20(0.47-3.07) 1.18(0.46-3.05)
Abbreviations: SC shared intensive care, UC usual care.
†Adjusted RR, derived from prevalence ratios that were adjusted for fasting plasma glucose and maternal body height that were marginally significant.
‡Large for gestational age was defined by gender and gestational age specific 90th percentiles.
§Defined as capillary blood glucose <1.7 mmol/L.
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http://www.translational-medicine.com/content/12/1/290with unadjusted RR of 2.40 (95% CI: 1.06-5.44) and ad-
justed RR of 2.35 (95% CI: 1.05-5.26). Gestational hyper-
tension was similar in the two groups. The rate of Apgar
score <7 was significantly reduced from 1.9% (7/361) in
the UC to nil in the SC (P = 0.016). However, the rates of
hypoglycemia in both groups were low and not statisti-
cally significant between the two groups. Over 60% of
women had caesarean delivery which was marginally
higher in the SC group than in the UC group with ad-
justed RR of 1.09 (95% CI: 0.99-1.21). Low birth weight
defined as birth weight <2500 grams, stillbirth and neo-
natal death, preterm birth and premature rupture of
membrane were all similar in the two groups (Table 3).
Subgroup analysis
The prevalence of overweight and obesity was 23.4% and
9.7% in the GDM women diagnosed by the IADPSG’scriteria only and 24.3%11.4% in the GDM women diag-
nosed by both the IADPSG’s and the WHO’s (P = 0.723).
The SC reduced birth weight of 68 grams among women
with GDM diagnosed by the IADPSG’s criteria only and
111 grams among women with GDM diagnosed by both
the IADPSG’s criteria and the WHO’s criteria (Table 4).
The RRs for macrosomia were similar among women with
GDM diagnosed by the IADPSG’s and by both sets of cri-
teria but LGA was only significant among women with
GDM diagnosed by both the IADPSG’s criteria and the
WHO’s criteria but not diagnosed by the IADPSG’s criteria
only. The rates of PIH were not statistically significant be-
tween the SC group and the UC group with diagnosed
GDM either by the IADPSG’s only or by both sets of cri-
teria. The magnitude of the RR for PIH was much larger
numerically among women with GDM diagnosed by
IADPSG’s only than by both sets of diagnostic criteria.
Table 4 Subgroup analysis of predefined pregnancy outcomes of women with gestational diabetes mellitus by assignment
UC SC SC vs. UC SC vs. UC
Outcomes Mean (SD) or n(%) Mean (SD) or n(%) P value Unadjusted RR (95% CI) Adjusted RR† (95% CI)
Among GDM diagnosed by the IADPSG’s criteria only
n 117 110
Birth weight, g 3522(590) 3454(496) 0.352
Birth weight ≥4.0 kg 25(21.4%) 14(12.7%) 0.085 0.60(0.32-1.09) 0.62(0.34-1.13)
Large for gestational age‡ 27(23.1%) 21(19.1%) 0.462 0.83(0.50-1.37) 0.88(0.54-1.46)
Pregnancy-induced hypertension 3(2.6%) 7(6.4%) 0.163 2.48(0.66-9.36) 2.48(0.67-9.26)
Among GDM diagnosed by both IADPSG’s and WHO’s criteria
n 244 229
Birth weight, g 3443(565) 3332(542) 0.030
Birth weight ≥4.0 kg 38(15.6%) 24(10.5%) 0.097 0.67(0.42-1.08) 0.67(0.41-1.09)
Large for gestational age‡ 45(18.4%) 23(10.0%) 0.009 0.54(0.34-0.87) 0.52(0.33-0.84)
Pregnancy-induced hypertension 13(5.3%) 20(8.7%) 0.146 1.64(0.84-3.22) 1.56(0.79-3.06)
Abbreviations: SC shared intensive care, UC usual care, IADPSG International Association of Diabetes and Pregnancy Study Group, WHO World Health Organization.
†Adjusted RR, derived from prevalence ratios that were adjusted for fasting plasma glucose and maternal body height that were marginally significant.
‡Large for gestational age was defined by gender and gestational age specific 90th percentiles.
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In the sensitivity analysis, all the variables listed in Table 1
were non-significant between the SC group and the UC
group, including body height (P = 0.869) and fasting glu-
cose on OGTT (P = 0.342). Inclusion of those women
who entered the trial during Nov 2010 to July 2011 atten-
uated the intervention effect on macrosomia and PIH to
non-significance (Table 5). However, LGA (SC vs. UC:
18.9% vs. 14.0%, P = 0.040) and Apgar score at 1 min <7
(SC vs. UC: 0.6% vs. 3.0%, P = 0.008) remained significant.
Preterm birth was also less frequent in the SC group than
in the UC group (4.7% vs. 7.9%, P = 0.047). On the other
hand, caesarean delivery was more frequent in the SC
group than in the UC group (71.5% vs. 64.3%, P = 0.018).
After further adjusting for whether the glycaemic control
target had been achieved at the 30th and 34th gestational
weeks in the main analysis, the magnitude of the RRs for
macrosomia (RR: 0.74, 95% CI: 0.42-1.30) and for LGA
(RR: 0.78, 95% CI: 0.47-1.29) were attenuated. However, the
RR for PIH was almost unchanged (RR: 1.78, 95% CI: 0.79
to 3.98) and that for preeclampsia was even slightly in-
creased (RR: 2.43, 95% CI: 0.86-6.86).
Further explorations of the role of physical activity in
the increased risks of PIH and preeclampsia were made
by including whether reaching the physical activity target
as a covariable. Adjustment for whether achieving the
physical activity target increased the RRs of SC vs. UC
for PIH (RR:2.52, 95% CI: 1.10-5.79) and preeclampsia
(RR:3.65, 95% CI: 1.06-12.58).
Discussion
Gestational diabetes is associated with adverse pregnancy
outcomes and intensive intervention to normalise bloodglucose has been shown to improve outcomes among
women with mild GDM diagnosed by the WHO’s
criteria [11] and the Fourth International Workshop-
Conference on GDM’s criteria [9,10]. Using a pragmatic
randomised trial design, we demonstrated that intensive
lifestyle intervention was able to improve pregnancy
outcomes among women diagnosed by the new IADPSG’s
criteria [13].
In the ACHOIS [10], intensive management reduced
the rate of serious adverse pregnancy perinatal complica-
tions but the US trial did not find that intensive manage-
ment reduced the rate of infant morbidity [9]. In our
study, none of the pregnancies had birth trauma, shoul-
der dystocia, bone fracture and nerve palsy, possibly due
to the high rate of caesarean delivery of 60-70%, a rate
much higher than in US and Australia [9,10]. There was
around 1% of stillbirth or neonatal death in both groups
which was comparable to that in the US trial [9]. In the
ACHOIS, there was a 53% risk reduction in macrosomia
and 38% risk reduction in LGA [10] while the respective
rates in the US trial were 59% and 51% [9]. Thus, the
risk reductions of 34-36% for macrosomia and LGA in
our trial were smaller than those in the ACHOIS and
the US trial, which may be partially attributable to the
nature of our pragmatic trial.
In contrast to the two trials conducted in US and
Australia that showed decreased risk of preeclampsia or
PIH with intervention [9,10], our study did not find that
the intervention was able to reduce the risk of PIH but sug-
gested a significant increased risk of preeclampsia. The
ACHOIS [10] and the US trial [9] did not document phys-
ical activity. Two small trials [28] failed to generate conclu-
sive findings due to shortfall of power (RR of moderate
Table 5 Sensitivity analysis of pregnancy outcomes of 936 women with gestational diabetes mellitus by assignment
UC (n = 470) SC (n = 466) SC vs. UC
Outcomes Mean (SD) or n(%) Mean (SD) or n(%) P value Unadjusted RR (95% CI)
Delivery at a tertiary hospital 314(66.8%) 334(71.7%) 0.107
Gestational weeks at delivery 39.1(2.1) 39.4(2.5) 0.063
Primary outcome
Birth weight ≥4.0 kg 73(15.6%) 58(12.5%) 0.170 0.80(0.58-1.10)
Secondary outcome
Pregnancy-induced hypertension 22(4.7%) 33(7.1%) 0.118 1.51(0.90-2.56)
Other infant outcomes
Birth weight, g 3445(587) 3415(527) 0.412
Body stature of neonates, cm 50.2(2.0) 50.2(1.8) 0.694
Infant male gender 244(51.9%) 271(58.2%) 0.055
Large for gestational age† 89(18.9%) 65(14.0%) 0.040 0.74(0.55-0.99)
Birth weight ≥4.5 kg 12(2.6%) 14(3.0%) 0.679 1.17(0.55-2.51)
Birth weight < 2.5 kg 22(4.7%) 15(3.2%) 0.251 0.68(0.36-1.31)
Apgar score at 1 min <7 14(3.0%) 3(0.6%) 0.008 0.22(0.06-0.75)
Neonatal hypoglycemia‡ 4(0.9%) 2(0.4%) 0.418 0.50(0.09-2.74)
Birth trauma or shoulder dystocia 0 0 - -
Bone fracture 0 0 - -
Stillbirth or neonatal death 5(1.1%) 5(1.1%) 0.989 1.01(0.29-3.46)
Other maternal or delivery outcomes
Induced labor 2(0.4%) 0 0.500
Preterm birth 37(7.9%) 22(4.7%) 0.047 0.60(0.36-1.00)
Premature rupture of membrane 83(17.7%) 74(15.9%) 0.466 0.90(0.68-1.20)
Caesarean delivery 302(64.3%) 333(71.5%) 0.018 1.11(1.02-1.22)
Preeclampsia 12(2.6%) 21(4.5%) 0.105 1.76(0.88-3.55)
Gestational hypertension 10(2.1%) 12(2.6%) 0.651 1.21(0.53-2.77)
Abbreviations: SC shared intensive care, UC usual care.
†Large for gestational age was defined by gender and gestational age specific 90th percentiles.
‡Defined as capillary blood glucose <1.7 mmol/L.
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7.09). In our study, adjustment for physical activity in-
creased but not decreased the RRs for PIH and pre-
eclampsia, suggesting that physical activity was unlikely to
account for the increased risks of PIH and preeclampsia
in the SC group.
Although being supported by strong epidemiological
evidence from the HAPO study, there are still ongoing
debates on use of the new IADPSG’s criteria [29]. One
of the concerns is that there is no clinical evidence
showing the benefits of intervention for the fasting PG
threshold in the new criteria [30]. There are also on-
going debates whether prepregnancy obesity/overweight
or IADPSG-defined GDM contributes more to LGA
[31,32]. In addition to overall effectiveness for IADPSG’s
criteria-defined GDM, our trial also showed that the ef-
fect size of the intervention for macrosomia was similarin GDM diagnosed by the IADPSG’s only and by both
the WHO’s and the IADPSG’s although the prevalence
of obesity and overweight was similar in the two groups,
supporting use of the IADPSG’s criteria in Chinese preg-
nant women. However, the intervention for LGA seems
to be more effective for WHO-defined GDM than
IADPSG-defined GDM, which needs further elucidation.
In the subgroup analysis, the RR of the intervention for
PIH was numerically larger among women with GDM
diagnosed by the IADPSG’s criteria only than by both
sets of criteria. However, it is worth noting that the sam-
ple size of PIH cases in the IADPSG’s criteria only group
was small and we can not rule out that the larger RRs in
the former group was due to chance.
Our study has strong pragmatic implications, espe-
cially for developing countries. In China, the prevalence
of diabetes [33] and GDM [17] has been increasing
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system are in high demand for coping with the marked
increase in the prevalence of diabetes and GDM. Shared
management between different care teams is one way to
improve the quality of care. In this randomised study,
shared care between TWCHC GDM clinic and hospitals
within a 3-tier system with particular focus on lifestyle
modifications reduced risks of macrosomia and LGA by
34-36% in Chinese women with mild GDM that were,
at least, partially attributable to achievement of the gly-
caemic control target.
This trial had strengths and limitations. First, this was
a population-based pragmatic quality improvement pro-
gram implemented within a 3-tier antenatal care system
in a developing country. In this regard, experts have now
recommended care professionals to use pragmatic and
multipronged strategies to translate evidence to clinical
practice with ongoing evaluation [34]. Second, only two-
thirds of women were evaluated for clinical assessment
at the 34th gestational week follow-up. The results of the
analysis of these intermediate measurements need to be
interpreted with caution. Third, although women re-
cruited in the trial were blinded to their assignment sta-
tus and the two groups of women were asked to come
back on follow-up visits at different times and different
areas, the care providers were not blinded to the status
of assignment. The increased awareness of GDM in both
the subjects and care providers might change the practice
and bias due to the increased awareness could not be
excluded. Nevertheless, the similar rates of delivery at a ter-
tiary care hospital and use of insulin at delivery in the two
arms suggested that the main effects were unlikely to be
severely biased.
Conclusion
In this randomised quality improvement program, life-
style intervention in a 3-tier’s shared management system
reduced rates of macrosomia, LGA and neonatal Apgar
score at 1 min <7 in women with mild GDM diagnosed
with the IADPSG’s criteria. Our findings may be applicable
to developing countries where antenatal care is shared
among different care providers. However, the increased risk
of preeclampsia needs further investigations.
Additional file
Additional file 1: Flow Chart Showing the Care Protocols for
Women with GDM and Evaluation of Pregnancy Outcomes.
Abbreviations
ACHOIS: Australian carbohydrate intolerance study in pregnant women;
BMI: Body mass index; CI: Confidence interval; GCT: Glucose challenge test;
GDM: gestational diabetes mellitus; IADPSG: International association of
diabetes and pregnancy study groups; IQR: Interquartile range; LGA: Large
for gestational age; OGTT: Oral glucose tolerance test; PG: Plasma glucose;PHQ: Patient health questionnaire; RR: Relative risk; SC: Shared care; SD: Standard
deviation; SMBG: Self monitoring of blood glucose; TWCHC: Tianjin Women and
Children’s Health Centre; UC: Usual care; WCHC: Women and Children’s Health
Centres; WHO: World Health Organization.
Competing interests
JCNC was a member of the IDF-Western Pacific Region Executive Board and
IDF Adhoc committee for global plan of action for prevention of diabetes
and chronic diseases. Her institution has received research funding from
Eli Lilly and she is a member of advisory committee and speaker forum
sponsored by Eli Lilly. Other authors have nothing to declare.
Authors’ contribution
XY designed the study, analysed the data and drafted the manuscript; HT
designed the study, gave critical comments on the manuscript; FZ, CZ, YL, JL,
LW, GL, LD provided the study material and patients, collected and assembly
the data, gave critical comments on the manuscript; ZY, GH, and JC designed
the study, gave critical comments and edited the manuscripts. All authors read
and approved the final manuscript.
Acknowledgement
This project is supported by BRIDGES [Grant number: LT09-227]. BRIDGES is
an International Diabetes Federation program supported by an educational
grant from Lilly Diabetes. The authors thank all the health professionals of
Tianjin Antenatal Care Network for their involvement in and contribution to
the study. X.Y. was the guarantor of this manuscript.
Author details
1Department of Epidemiology and Biostatistics, School of Public Health,
Tianjin Medical University, Tianjin 300070, China. 2Department of Medicine
and Therapeutics, Hong Kong Institute of Diabetes and Obesity, The Chinese
University of Hong Kong and The Chinese University of Hong Kong-Prince
of Wales Hospital-International Diabetes Federation Centre of Education,
Hong Kong, China. 3Tianjin Women and Children’s Health Centre, Tianjin,
China. 4Population Cancer Research Program and Department of Pediatrics,
Dalhousie University, Halifax, Canada. 5Chronic Disease Epidemiology
Laboratory, Pennington Biomedical Research Center, Baton Rouge,
Louisiana, USA.
Received: 20 August 2014 Accepted: 7 October 2014
References
1. Yang X, Hsu-Hage B, Zhang H, Zhang C, Zhang Y, Zhang C: Women with
impaired glucose tolerance during pregnancy have significantly poor
pregnancy outcomes. Diabetes Care 2002, 25:1619–1624.
2. Rosenberg TJ, Garbers S, Lipkind H, Chiasson MA: Maternal obesity and
diabetes as risk factors for adverse pregnancy outcomes: differences
among 4 racial/ethnic groups. Am J Public Health 2005, 95:1545–1551.
3. Weiner CP: Effect of varying degrees of "normal" glucose metabolism on
maternal and perinatal outcome. Am J Obstet Gynecol 1988, 159:862–870.
4. Hod M, Merlob P, Friedman S, Schoenfeld A, Ovadia J: Gestational diabetes
mellitus. A survey of perinatal complications in the 1980s. Diabetes 1991,
40:74–78.
5. Maresh M, Beard RW, Bray CS, Elkeles RS, Wadsworth J: Factors
predisposing to and outcome of gestational diabetes. Obstet Gynecol
1989, 74:342–346.
6. Whitaker RC, Pepe MS, Seidel KD, Wright JA, Knopp RH: Gestational
diabetes and the risk of offspring obesity. Pediatrics 1998, 101:E9.
7. Feig DS, Zinman B, Wang X, Hux JE: Risk of development of diabetes
mellitus after diagnosis of gestational diabetes. CMAJ 2008, 179:229–234.
8. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR,
Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B,
Rogers MS, Sacks DA: Hyperglycemia and adverse pregnancy
outcomes. N Engl J Med 2008, 358:1991–2002.
9. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B,
Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A, Catalano P,
Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE,
Anderson GB: A multicenter, randomized trial of treatment for mild
gestational diabetes. N Engl J Med 2009, 361:1339–1348.
Yang et al. Journal of Translational Medicine 2014, 12:290 Page 11 of 11
http://www.translational-medicine.com/content/12/1/29010. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS:
Effect of treatment of gestational diabetes mellitus on pregnancy
outcomes. N Engl J Med 2005, 352:2477–2486.
11. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes
mellitus and its complications. Part 1: diagnosis and classification of
diabetes mellitus provisional report of a WHO consultation. Diabet Med
1998, 15:539–553.
12. Metzger BE, Coustan DR: Summary and recommendations of the Fourth
International Workshop-Conference on Gestational Diabetes Mellitus.
The Organizing Committee. Diabetes Care 1998, 21(Suppl 2):B161–B167.
13. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P,
Dyer AR, Leiva A, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ,
Omori Y, Schmidt MI: International association of diabetes and
pregnancy study groups recommendations on the diagnosis and
classification of hyperglycemia in pregnancy. Diabetes Care 2010,
33:676–682.
14. Morikawa M, Yamada T, Akaishi R, Nishida R, Cho K, Minakami H: Change in
the number of patients after the adoption of IADPSG criteria for
hyperglycemia during pregnancy in Japanese women. Diabetes Res Clin
Pract 2010, 90:339–342.
15. O'Sullivan EP, Avalos G, O'Reilly M, Dennedy MC, Gaffney G, Dunne F:
Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of
gestational diabetes mellitus using new diagnostic criteria. Diabetologia
2011, 54:1670–1675.
16. Yang X, Hsu-Hage B, Zhang H, Yu L, Dong L, Li J, Shao P, Zhang C:
Gestational diabetes mellitus in women of single gravidity in Tianjin City,
China. Diabetes Care 2002, 25:847–851.
17. Zhang F, Dong L, Zhang CP, Li B, Wen J, Gao W, Sun S, Lv F, Tian H,
Tuomilehto J, Qi L, Zhang CL, Yu Z, Yang X, Hu G: Increasing prevalence of
gestational diabetes mellitus in Chinese women from 1999 to 2008.
Diabet Med 2011, 28:652–657.
18. Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, Halperin I,
Vachon B, Ramsay T, Manns B, Tonelli M, Shojania K: Effectiveness of
quality improvement strategies on the management of diabetes: a
systematic review and meta-analysis. Lancet 2012, 379:2252–2261.
19. So WY, Chan JC: The Role of the Multidisciplinary Team. In Textbook of
Diabetes. 4th edition. Edited by Holt R, Cockram S, Flyvbjerg A, Goldstein B.
Oxford, UK: Wiley-Blackwell; 2010:969–983.
20. American Diabetes Association: Diagnosis and classification of diabetes
mellitus. Diabetes Care 2010, 33(Suppl 1):S62–S69.
21. Chen C, Lu FC: The guidelines for prevention and control of overweight
and obesity in Chinese adults. Biomed Environ Sci 2004, 17(Suppl):1–36.
22. Zhang Y, Ting R, Lam M, Lam J, Nan H, Yeung R, Yang W, Ji L, Weng J, Wing YK,
Sartorius N, Chan JC: Measuring depressive symptoms using the Patient
Health Questionnaire-9 in Hong Kong Chinese subjects with type 2 diabetes.
J Affect Disord 2013, 151:660–666.
23. Yu X, Tam WW, Wong PT, Lam TH, Stewart SM: The Patient Health
Questionnaire-9 for measuring depressive symptoms among the general
population in Hong Kong. Compr Psychiatry 2012, 53:95–102.
24. Nan H, Lee PH, McDowell I, Ni MY, Stewart SM, Lam TH: Depressive
symptoms in people with chronic physical conditions: prevalence and
risk factors in a Hong Kong community sample. BMC Psychiatry 2012,
12:198.
25. Ma G, Luan D, Li Y, Liu A, Hu X, Cui Z, Zhai F, Yang X: Physical activity level
and its association with metabolic syndrome among an employed
population in China. Obes Rev 2008, 9(Suppl 1):113–118.
26. Fattah C, Farah N, Barry SC, O'Connor N, Stuart B, Turner MJ: Maternal
weight and body composition in the first trimester of pregnancy.
Acta Obstet Gynecol Scand 2010, 89:952–955.
27. Spiegelman D, Hertzmark E: Easy SAS calculations for risk or prevalence
ratios and differences. Am J Epidemiol 2005, 162:199–200.
28. Meher S, Duley L: Exercise or other physical activity for preventing
pre-eclampsia and its complications. Cochrane Database Syst Rev
2006, CD005942.
29. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PM, Damm P,
Dyer AR, Hod M, Kitzmiller JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y: The
diagnosis of gestational diabetes mellitus: new paradigms or status quo?
J Matern Fetal Neonatal Med 2012, 25:2564–2569.30. Holt RI, Coleman MA, McCance DR: The implications of the new
International Association of Diabetes and Pregnancy Study Groups
(IADPSG) diagnostic criteria for gestational diabetes. Diabet Med 2011,
28:382–385.
31. McIntyre HD, Catalano PM: Comment on: Black et al. The relative
contribution of prepregnancy overweight and obesity, gestational
weight gain, and IADPSG-defined gestational diabetes mellitus to fetal
overgrowth. Diabetes Care 2013;36:56–62. Diabetes Care 2013, 36:e127.
32. Black MH, Sacks DA, Xiang AH, Lawrence JM: The relative contribution of
prepregnancy overweight and obesity, gestational weight gain, and
IADPSG-defined gestational diabetes mellitus to fetal overgrowth.
Diabetes Care 2013, 36:56–62.
33. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N,
Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W,
Zhao W, Ning G: Prevalence and control of diabetes in Chinese adults.
JAMA 2013, 310:948–959.
34. Marshall M, Pronovost P, Dixon-Woods M: Promotion of improvement as a
science. Lancet 2013, 381:419–421.
doi:10.1186/s12967-014-0290-2
Cite this article as: Yang et al.: A randomised translational trial of lifestyle
intervention using a 3-tier shared care approach on pregnancy outcomes
in Chinese women with gestational diabetes mellitus but without diabetes.
Journal of Translational Medicine 2014 12:290.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
